Paul M. Ossenkoppele

628 total citations
14 papers, 441 citations indexed

About

Paul M. Ossenkoppele is a scholar working on Immunology, Dermatology and Economics and Econometrics. According to data from OpenAlex, Paul M. Ossenkoppele has authored 14 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Dermatology and 5 papers in Economics and Econometrics. Recurrent topics in Paul M. Ossenkoppele's work include Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Paul M. Ossenkoppele is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Paul M. Ossenkoppele collaborates with scholars based in Netherlands and United States. Paul M. Ossenkoppele's co-authors include M.D. Njoo, E.M.G.J. de Jong, M.I.A. Koetsier, J.M. Mommers, Wietske Kievit, P.C.M. van de Kerkhof, Marisol E. Otero, W.P. Arnold, A.L.A. Kuijpers and J M Ossewaarde and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and British Journal of Dermatology.

In The Last Decade

Paul M. Ossenkoppele

11 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul M. Ossenkoppele Netherlands 10 316 171 89 85 81 14 441
J.L. Sánchez‐Carazo Spain 14 268 0.8× 204 1.2× 94 1.1× 108 1.3× 10 0.1× 38 470
M. Alsina‐Gibert Spain 9 175 0.6× 83 0.5× 24 0.3× 104 1.2× 15 0.2× 23 329
Marcelo Arnone Brazil 11 132 0.4× 75 0.4× 14 0.2× 34 0.4× 23 0.3× 29 273
J.M. Hernánz Spain 13 249 0.8× 204 1.2× 74 0.8× 78 0.9× 2 0.0× 28 445
Hilde Carlier United States 12 390 1.2× 83 0.5× 19 0.2× 84 1.0× 26 644
Maud Pacou United Kingdom 8 44 0.1× 76 0.4× 11 0.1× 159 1.9× 4 0.0× 27 307
Dilek Arikan United States 11 144 0.5× 47 0.3× 17 0.2× 90 1.1× 25 417
Silja Domm Germany 8 215 0.7× 162 0.9× 6 0.1× 79 0.9× 12 346
S Manners Canada 3 153 0.5× 18 0.1× 21 0.2× 258 3.0× 5 0.1× 5 609
Tanawin Nopsopon United States 12 34 0.1× 8 0.0× 12 0.1× 91 1.1× 6 0.1× 44 430

Countries citing papers authored by Paul M. Ossenkoppele

Since Specialization
Citations

This map shows the geographic impact of Paul M. Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Ossenkoppele more than expected).

Fields of papers citing papers by Paul M. Ossenkoppele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Ossenkoppele. The network helps show where Paul M. Ossenkoppele may publish in the future.

Co-authorship network of co-authors of Paul M. Ossenkoppele

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Ossenkoppele. A scholar is included among the top collaborators of Paul M. Ossenkoppele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Ossenkoppele. Paul M. Ossenkoppele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Otero, Marisol E., J. M. P. A. van den Reek, E.M.G.J. de Jong, et al.. (2024). Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasis. Clinical and Experimental Dermatology. 50(2). 348–356.
2.
Berends, Sophie E., Hans Groenewoud, Ron A. A. Mathôt, et al.. (2022). Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. Journal of Dermatological Treatment. 33(5). 2680–2684. 8 indexed citations
3.
Ossenkoppele, Paul M., et al.. (2021). [Granuloma annulare after herpes zoster: Wolf's isotopic response].. PubMed. 165.
4.
5.
Reek, J.M.P.A. van den, Marisol E. Otero, M.D. Njoo, et al.. (2020). Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study. Acta Dermato Venereologica. 100(19). adv00340–adv00340. 12 indexed citations
6.
Reek, J.M.P.A. van den, Alfons A den Broeder, Lieke J. van Vugt, et al.. (2020). Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis. JAMA Dermatology. 156(4). 393–393. 34 indexed citations
7.
Reek, J.M.P.A. van den, J.M.M. Groenewoud, Marisol E. Otero, et al.. (2019). Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry. Journal of the European Academy of Dermatology and Venereology. 33(10). 1913–1920. 33 indexed citations
8.
Reek, J.M.P.A. van den, Lieke J. van Vugt, Martijn B. A. van Doorn, et al.. (2018). Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study. Acta Dermato Venereologica. 98(7). 648–654. 48 indexed citations
9.
10.
Zweegers, Jeffrey, J.M.M. Groenewoud, J. M. P. A. van den Reek, et al.. (2016). Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry. British Journal of Dermatology. 176(4). 1001–1009. 38 indexed citations
11.
Reek, J.M.P.A. van den, Marisol E. Otero, Jeffrey Zweegers, et al.. (2014). Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. British Journal of Dermatology. 170(5). 1158–1165. 24 indexed citations
12.
Reek, J. M. P. A. van den, Jeffrey Zweegers, Wietske Kievit, et al.. (2014). ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetwork. British Journal of Dermatology. 171(5). 1189–1196. 77 indexed citations
13.
Zweegers, Jeffrey, J. M. P. A. van den Reek, Marisol E. Otero, et al.. (2014). Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: Bio CAPTURE. British Journal of Dermatology. 171(5). 1091–1098. 19 indexed citations
14.
Ossewaarde, J M, et al.. (1992). Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis. Journal of Clinical Microbiology. 30(8). 2122–2128. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.L. Sánchez‐Carazo Breakdown of academic impact, for papers by M. Alsina‐Gibert Breakdown of academic impact, for papers by Marcelo Arnone Breakdown of academic impact, for papers by J.M. Hernánz Breakdown of academic impact, for papers by Hilde Carlier Breakdown of academic impact, for papers by Maud Pacou Breakdown of academic impact, for papers by Dilek Arikan Breakdown of academic impact, for papers by Silja Domm Breakdown of academic impact, for papers by S Manners Breakdown of academic impact, for papers by Tanawin Nopsopon
Rankless by CCL
2026